Free Trial

Viridian Therapeutics (VRDN) Competitors

Viridian Therapeutics logo
$14.44 -0.23 (-1.57%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$14.44 0.00 (-0.03%)
As of 03/28/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VRDN vs. RDNT, SHC, BTSG, SGRY, WGS, PRVA, CON, LFST, VCYT, and ARDT

Should you be buying Viridian Therapeutics stock or one of its competitors? The main competitors of Viridian Therapeutics include RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), GeneDx (WGS), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), Veracyte (VCYT), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry.

Viridian Therapeutics vs.

RadNet (NASDAQ:RDNT) and Viridian Therapeutics (NASDAQ:VRDN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, community ranking, profitability, earnings, institutional ownership and risk.

RadNet has a net margin of -0.25% compared to Viridian Therapeutics' net margin of -85,127.16%. RadNet's return on equity of 4.29% beat Viridian Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-0.25% 4.29% 1.45%
Viridian Therapeutics -85,127.16%-70.12%-41.49%

RadNet has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500. Comparatively, Viridian Therapeutics has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500.

RadNet has higher revenue and earnings than Viridian Therapeutics. Viridian Therapeutics is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$1.83B2.00$3.04M$0.031,648.00
Viridian Therapeutics$302K3,896.17-$237.73M-$3.77-3.83

RadNet currently has a consensus target price of $73.25, indicating a potential upside of 48.16%. Viridian Therapeutics has a consensus target price of $35.70, indicating a potential upside of 147.23%. Given Viridian Therapeutics' higher probable upside, analysts plainly believe Viridian Therapeutics is more favorable than RadNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.40
Viridian Therapeutics
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75

77.9% of RadNet shares are held by institutional investors. 5.1% of RadNet shares are held by insiders. Comparatively, 0.7% of Viridian Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

RadNet received 281 more outperform votes than Viridian Therapeutics when rated by MarketBeat users. However, 78.72% of users gave Viridian Therapeutics an outperform vote while only 66.23% of users gave RadNet an outperform vote.

CompanyUnderperformOutperform
RadNetOutperform Votes
355
66.23%
Underperform Votes
181
33.77%
Viridian TherapeuticsOutperform Votes
74
78.72%
Underperform Votes
20
21.28%

In the previous week, RadNet had 13 more articles in the media than Viridian Therapeutics. MarketBeat recorded 17 mentions for RadNet and 4 mentions for Viridian Therapeutics. Viridian Therapeutics' average media sentiment score of 1.39 beat RadNet's score of 0.66 indicating that Viridian Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
6 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Viridian Therapeutics
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

RadNet beats Viridian Therapeutics on 13 of the 19 factors compared between the two stocks.

Remove Ads
Get Viridian Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRDN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRDN vs. The Competition

MetricViridian TherapeuticsMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$1.18B$2.83B$5.63B$7.84B
Dividend YieldN/A22.59%5.33%4.01%
P/E Ratio-3.3513.1723.5818.74
Price / Sales3,896.17202.00388.2390.77
Price / CashN/A57.5638.1734.64
Price / Book3.224.356.894.23
Net Income-$237.73M-$22.21M$3.20B$247.47M
7 Day Performance-5.37%51.05%-3.06%-2.29%
1 Month Performance-7.02%12.95%1.51%-5.81%
1 Year Performance-17.53%-3.70%9.37%-0.96%

Viridian Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRDN
Viridian Therapeutics
1.1865 of 5 stars
$14.44
-1.6%
$35.70
+147.2%
-17.5%$1.18B$302,000.00-3.3550Positive News
RDNT
RadNet
3.9246 of 5 stars
$51.83
+5.2%
$73.25
+41.3%
+1.6%$3.84B$1.83B-740.328,970
SHC
Sotera Health
2.7105 of 5 stars
$12.21
+2.6%
$15.92
+30.4%
-2.0%$3.46B$1.10B48.843,000
BTSG
BrightSpring Health Services
2.7331 of 5 stars
$18.69
+3.5%
$21.67
+15.9%
+65.9%$3.27B$11.27B-71.8835,000Gap Up
SGRY
Surgery Partners
2.8119 of 5 stars
$24.39
+0.7%
$36.63
+50.2%
-19.7%$3.11B$3.11B-50.8113,500Analyst Forecast
WGS
GeneDx
2.1163 of 5 stars
$103.19
-1.1%
$72.33
-29.9%
+909.9%$2.90B$305.45M-52.651,200Insider Trade
Gap Up
PRVA
Privia Health Group
3.3227 of 5 stars
$23.92
+2.5%
$26.67
+11.5%
+15.3%$2.88B$1.74B239.221,102Positive News
CON
Concentra Group Holdings Parent
N/A$21.49
+3.2%
$28.50
+32.6%
N/A$2.74B$1.90B14.2311,000Positive News
LFST
LifeStance Health Group
2.5417 of 5 stars
$6.76
-1.3%
$8.63
+27.6%
+8.6%$2.60B$1.25B-26.009,325Positive News
VCYT
Veracyte
4.532 of 5 stars
$33.16
+4.2%
$43.22
+30.3%
+35.9%$2.58B$445.76M-221.07790Analyst Forecast
News Coverage
Positive News
ARDT
Ardent Health Partners
N/A$13.30
+1.2%
$21.18
+59.2%
N/A$1.90B$5.97B0.0024,200Analyst Forecast
News Coverage
Positive News
Remove Ads

Related Companies and Tools


This page (NASDAQ:VRDN) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners